arrow_back Back Filing freshness 40-F FY 2024 SEC EDGAR

download Export Data

Ayr Wellness Inc.

AYRWF

— Price unavailable

6 Visible periods

28 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

Ayr Wellness Inc. faces fundamental challenges with weakness in Return on Common Equity (%) and Profit Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap —

Dividend Yield —

Revenue Growth 0.0% ↘

Op. Margin -34.7% ↘

ROIC -23.1% ↘

FCF / Share $-72.94

Trailing P/E —

Price / Book —

FCF Yield —

Debt / Equity 1.08

info Valuation on last close.

6-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$463.63M

— 0.0% —

Net Income Profit after all expenses

$-359.31M

↓ -31.9% —

Operating Margin Operating profit as % of sales

-34.7%

↓ -332.6% 7th

Long-Term Debt Long-term obligations

$410.47M

↑ +145.3% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Operating Margin (%)Operating Margin (%) is in the bottom quartile
Profit Margin (%)Profit Margin (%) is in the bottom quartile
Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability ↑

Returns ↓

Financial Health ↑

Cash Quality ↓

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 3 metrics

Metric	FY 2024 Dec 31, 2024 40-F ↗	FY 2023 Dec 31, 2023 40-F ↗	FY 2022 Dec 31, 2022 40-F ↗	FY 2021 Dec 31, 2021 40-F ↗	FY 2020 Dec 31, 2020 40-F ↗	FY 2019 Dec 31, 2019 40-F ↗
Revenue Growth YoY (%)	0.0% Caution Caution Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-100%)	10.0% Good Good Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+100%)	—	—	—	—
EPS Growth YoY (%)	12.0% Fair Fair Year-over-year change in earnings per share Optimal: > 10%	-2.8% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—
Net Income Growth YoY (%)	-31.9% Weak ↑ Weak Improving Year-over-year change in net income	-11.0% Weak ↑ Weak Improving Year-over-year change in net income	-1348.0% Weak Weak Year-over-year change in net income	31.1% Excellent Excellent Year-over-year change in net income	—	—

💰 Are margins durable? 5 metrics

Metric	FY 2024 Dec 31, 2024 40-F ↗	FY 2023 Dec 31, 2023 40-F ↗	FY 2022 Dec 31, 2022 40-F ↗	FY 2021 Dec 31, 2021 40-F ↗	FY 2020 Dec 31, 2020 40-F ↗	FY 2019 Dec 31, 2019 40-F ↗
Operating Margin (%) (%)	-34.7% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-331%)	-8.0% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-154%)	-49.2% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-428%)	—	—	—
Effective Tax Rate (%) (%)	-13.6% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-103.6% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	-26.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—
Profit Margin (%) (%)	-77.5% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-875%)	-58.8% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-688%)	-58.2% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-682%)	—	—	—
FCF Margin (%) (%)	-1.7% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-0.1% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-22.1% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—
FCF / Net Income (x)	0.02x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.00x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.38x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2024 Dec 31, 2024 40-F ↗	FY 2023 Dec 31, 2023 40-F ↗	FY 2022 Dec 31, 2022 40-F ↗	FY 2021 Dec 31, 2021 40-F ↗	FY 2020 Dec 31, 2020 40-F ↗	FY 2019 Dec 31, 2019 40-F ↗
Return on Invested Capital (%)	-23.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-10.1% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	-26.9% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—	—	—
Return on Capital (%) (%)	-12.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-2.5% Weak Weak Operating profit relative to total assets Optimal: > 10%	-11.7% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—
Return on Common Equity (%) (%)	-94.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-889%)	-46.8% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-490%)	-29.5% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-345%)	—	—	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	FY 2024 Dec 31, 2024 40-F ↗	FY 2023 Dec 31, 2023 40-F ↗	FY 2022 Dec 31, 2022 40-F ↗	FY 2021 Dec 31, 2021 40-F ↗	FY 2020 Dec 31, 2020 40-F ↗	FY 2019 Dec 31, 2019 40-F ↗
Debt to Equity (x)	1.08x Caution ↑ Caution Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+116%)	0.29x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-42%)	0.16x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-67%)	—	—	—
Interest Coverage (x)	-2.06x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-0.94x Weak Weak Operating income divided by interest expense Optimal: > 5x	-7.32x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—
Net Debt (USD)	$410.47M	$116.58M	$59.49M	—	—	—
Debt / EBITDA (x)	-3.09x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-34.08x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.72x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	—

📊 What does each share earn? 6 metrics

Metric	FY 2024 Dec 31, 2024 40-F ↗	FY 2023 Dec 31, 2023 40-F ↗	FY 2022 Dec 31, 2022 40-F ↗	FY 2021 Dec 31, 2021 40-F ↗	FY 2020 Dec 31, 2020 40-F ↗	FY 2019 Dec 31, 2019 40-F ↗
Revenue per Share (USD)	$4.18K	—	—	—	—	—
Basic EPS, GAAP (USD)	$-3.24	$-3.68	$-3.58	—	—	—
Free Cash Flow per Share (USD)	$-72.94	—	—	—	—	—
Book Value per Share (USD)	$3.42K	—	—	—	—	—
Tangible Book Value per Share (USD)	$-2.14K	—	—	—	—	—
Basic Weighted Avg Shares (shares)	110,832	74,096	68,635	—	—	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	FY 2024 Dec 31, 2024 40-F ↗	FY 2023 Dec 31, 2023 40-F ↗	FY 2022 Dec 31, 2022 40-F ↗	FY 2021 Dec 31, 2021 40-F ↗	FY 2020 Dec 31, 2020 40-F ↗	FY 2019 Dec 31, 2019 40-F ↗
Working Capital (USD)	$65.84M	$-7.26M	$184.90M	—	—	—
LT Debt (USD)	$410.47M	$167.35M	$136.31M	—	—	—
Total Equity (USD)	$379.53M	$581.78M	$833.32M	—	—	—

📋 What is driving earnings? 4 metrics

Metric	FY 2024 Dec 31, 2024 40-F ↗	FY 2023 Dec 31, 2023 40-F ↗	FY 2022 Dec 31, 2022 40-F ↗	FY 2021 Dec 31, 2021 40-F ↗	FY 2020 Dec 31, 2020 40-F ↗	FY 2019 Dec 31, 2019 40-F ↗
Sales/Revenue/Turnover (USD)	$463.63M	$463.63M	$421.44M	—	—	—
Depreciation Expense (USD)	$28.23M	$32.30M	$19.03M	—	—	—
Net Income, GAAP (USD)	$-359.31M	$-272.43M	$-245.47M	$-16.95M	$-24.61M	—
Operating Cash Flow (USD)	$9.63M	$27.16M	$-34.16M	—	—	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 6 years · 6 quarters

Ayr Wellness Inc.

Analytical Summary

6-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare AYRWF with peers